Skip to main content

Table 1 A summary of AD studies that have measured grey matter diffusion changes

From: Diffusion imaging changes in grey matter in Alzheimer’s disease: a potential marker of early neurodegeneration

Study

Familial or sporadic

n

Methods

Main findings

Kantarci et al. 2005 [17]

Sporadic

21 MCI, 54 NC

Hippocampi manually segmented. Volume and MD measured. 36 month clinical follow-up

Hippocampal MD better than hippocampal volume for predicting conversion from MCI to AD over the 36 month follow-up

Muller et al. 2005 [18]

Sporadic

18 MCI, 18 NC

Hippocampi manually segmented. Volume, MD + FA measured

Increased MD in hippocampus is strongest independent predictor of episodic memory decline, and is more sensitive than volume loss

Fellgiebel et al. 2006 [31]

Sporadic

18 MCI

Hippocampi manually segmented. Volume and MD measured. 18 month clinical follow-up with convertors and non-convertors compared

Increased left hippocampal MD at baseline in convertors compared with non-convertors

Rose et al. 2008 [33]

Sporadic

13 AD, 13 NC

Voxelwise GM MD analysis

Elevated MD in hippocampus, amygdala,

and medial temporal, parietal, and frontal GM in AD. Largest number of abnormal voxels in PCC

Scola et al. 2010 [34]

Sporadic

21 AD, 21 MCI, 20 NC

Whole brain GM + WM MD; followed by ROI analysis. 2 year clinical follow-up with MCI convertors and non-convertors compared

Trend seen over normal/MCI/AD for GM + WM MD. Volume alone could not predict convertors, but diffusivity could

Kantarci et al. 2010 [35]

Sporadic

30 AD, 30 DLB, 60 NC

ROI analysis using FLAIR diffusion imaging, measuring MD (plus volumes) in GM

Compared to DLB, AD has elevated MD in hippocampi, parahippocampal gyri, amygdala, temporoparietal association cortices, PCC + precuneus. Measuring MD increases ability to identify AD

Douaud et al. 2013 [32]

Sporadic

35 MCI

Voxelwise GM MD measured, with convertors and non-convertors compared (36 month follow-up)

Elevated left hippocampal and amygdala MD in convertors. Left hippocampal MD was the best predictor of conversion

Jacobs et al. 2013 [36]

Sporadic

20 MCI, 20 NC

Whole-brain CTh, MD analysis on GM. ROI analysis then applied

MCI showed increased MD in precuneus, PCC, supramarginal + frontal cortices; largest effect in the PCC

Fortea et al. 2010 [39]

Familial

6 PMC, 5 SMC, 18 NC

ROI analysis of cortical and subcortical GM MD (plus CTh and subcortical volumes)

Reduced MD (plus CTh) in precuneus, PCC + parietotempral association cortices in PMCs Widespread elevated MD in SMCs

Ryan et al. 2013 [38]

Familial

10 PMC, 10 SMC, 20 NC

ROI MD and FA (GM and WM) + GM volumes

In PMC, reduced MD in right hippocampus (without atrophy) + cingulum, with increased FA in thalamus and caudate. In SMCs MD rises

  1. AD, Alzheimer’s disease; CTh, cortical thickness; DLB, Dementia with Lewy bodies; FA, fractional anisotropy; GM, grey matter; MCI, mild cognitive impairment; MD, mean diffusivity; NC normal control; PCC, posterior cingulate cortex; PMC, presymptomatic mutation carrier; ROI, region of interest; SMC, symptomatic mutation carrier; WM, white matter